Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.621
-0.029 (-4.52%)
Mar 9, 2026, 3:06 PM EDT - Market open
Cellyan Biotechnology Employees
Cellyan Biotechnology had 27 employees as of March 31, 2025. The number of employees increased by 8 or 42.11% compared to the previous year.
Employees
27
Change (1Y)
8
Growth (1Y)
42.11%
Revenue / Employee
$752,364
Profits / Employee
-$1,002
Market Cap
6.83M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27 | 8 | 42.11% |
| Mar 31, 2024 | 19 | -17 | -47.22% |
| Mar 31, 2023 | 36 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,200 |
| Novartis AG | 75,267 |
| AbbVie | 57,000 |
| Eli Lilly and Company | 50,000 |
| Evogene | 117 |
| enVVeno Medical | 37 |
| Kiora Pharmaceuticals | 12 |
| Immuron | 7 |
HKPD News
- 7 weeks ago - Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency - GlobeNewsWire
- 2 months ago - Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders - GlobeNewsWire
- 3 months ago - DCS Announces Q3 2025 Quarterly Financial Statements - Newsfile Corp
- 1 year ago - Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024 - PRNewsWire
- 1 year ago - U.S. IPO Weekly Recap: Oil And Gas Well Equipment Provider Flowco Debuts, While More Sizable Deals Join The Pipeline - Seeking Alpha
- 1 year ago - Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering - PRNewsWire